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SIN,TMARY
In the 1930s infectious diseases formed a major threat to public health. The
discovery and application of penicillin and other antimicrobial agens was one of
the most importrnt measures leading to the control of bacterial diseases. However,
extensive use of these antibiotics has led to the emergence of resistrnt strains. This
forces man to develop ever new antibiotics in a lasting race with microorganisms.
At present infectious diseases are still the world's number one cause of death
and a crisis in antibiotic resistance is announcing iself. Ever more pathogens
appear to be insensitive to ever more antibacterial agents.
Part of the solution to this crisis is on the social level. More stringent rules
have to be set up for the use of antibiotics in hospitals and in the community and
hygiene and health care in the slums of large cities in both the first and the third
world have to be improved. On the other hand ttre necessity to develop new
antibiotics remains. This development takes place mainly using a trial and error
approach. For more rational drug design it is essential to learn more about the
interaction between antibiotics and their targets.
The targets of penicillin and other /-lactam antibiotics are the penicillin-binding
proteins (PBPs). These proteins, which fulfil essential roles in the synthesis of the
bacterial cell wall, can be divided into two groups. The high-M, PBPs are bifunc-
tional enzymes forming the lethal trrgets of/Jactam antibiotics. The low-M, PBPs
are monofunctional and are therefore much easier to study. Since they show
considerable similarity to the high-M, PBPs they form suitable model systems.
In this thesis the structure function relationship of two low-M, PBPs of
Escherichia coli, PBPS and PBP6, was investigated. Structural and mechanistic
data of /-lactamases were used. /-I-actamases, which are related to PBPs,
hydrolyse/-lactam antibiotics and are largely responsible for bacterial resistance.
Studying the enzymatic characteristics of a protein and determining is three-
dimensional structure using X-ray diffraction, necessitates large quantities of
purified material. Chapter two describes an overexpression system for PBP5.
0verexpression of PBP5 in the periplasmic space causes lysis of ttre cells. By
removing the DNA coding for the sipal peptide a 2CI-fold cytoplasmic overex-
pression of PBP5 could be obtained. A new purification method for the purificati-
on of large quantities of both wild rype and mutated forms of PBP5 was set up.
Using the immobilized dye Procion rubine MX-B, PBP5 can be purified, indepen-
dent of a functional active site, in a one-step procedure.
Sequence comparisons with other PBPs and /Jactamases reveal that PBP5 has
an extra 100 residues at its C-terminus. The C-terminal l8 of these extra residues
form a membrane anchor. Removal of this anchor results in a soluble, enzymati-
cally active form of PBP5. In chapter three the domain structure of PBP5 was
investigated by introducing stopcodons at various points in the sequence. A
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shortened form of PBP5 missing 100 C-terminal amino acids still appeared to be
enzymatically active, although it was more sensitive to proteolytic degradation.
PBPs and /Jactamases are members of a family of penicillin recognizing
enzymes. A number of highly conserved amino acid motifs, all lining the active
site, can be identified in all these enzymes. Chapter four describes mutation of the
conserved residues using site-directed mutagenesis. The results emphasize the
importance of these residues for the enzymatic activity of PBP5 and confirm their
crucial role in catalysis.
Electron microscopy of thin sections revealed the formation of crystals in the
cytoplasm of cells accumulating PBP5. The oblong crystals extended through the
whole length of the cell, showing a substructure in bottr parallel and perpendicular
cross-sections. Investigation of these crystals using image processing is described
in chapter five.
In cooperation with the university of Liege in vitro crystallization experiments
have been carried out. Diffraction patterns of several soluble forms of PBP5 are
presented in chapter six.
Chapter seven describes a series of experiments concerning PBP6. Alttrough
PBP6 is described as having the same activity as PBP5, no D,D-carboxypeptidase
activity could be determined for purified PBP6. Overexpression of PBP6 does not
lead to lysis of the cells and ttrerefore the in vivo function of PBP6 also seems to
be different from PBP5. Since an elevated level of PBP6 has been observed in
strtionary-phase cells, this protein is probably involved in stabilization of peptido-
glycan during stationary-phase growth of the cell.
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